| AKT1 | Serine-threonine protein kinase AKT1 |
| APOBEC3 | Apolipoprotein B mRNA editing enzyme, catalytic subunit 3 |
| ARID1A | AT-rich interactive domain-containing protein 1A |
| ATM | Ataxia telangiectasia mutated |
| BCOR | BCL6 corepressor |
| BRCA2 | Breast cancer gene 2 |
| CCC | Clear cell adenocarcinoma |
| CDK12 | Cyclin dependent kinase 12 |
| CDKN2A | Cyclin dependent kinase inhibitor 2 |
| CIN | Cervical intraepithelial neoplasia |
| CTNNB1 | Catenin Beta 1 |
| DES | Diethylstilbestrol |
| DNA | Deoxyribonucleic acid |
| ECA | endocervical adenocarcinoma |
| EGFR | Epidermal growth factor receptor |
| ELF | Ets domain transcription factor |
| ENAC | Endometrioid adenocarcinoma |
| ERB2 | Erb-B2 receptor tyrosine kinase 2 |
| FBXW7 | F-box and WD repeat domain containing 7 |
| FDA | Food and Drug Administration |
| FGFR2 | fibroblast growth factor receptor 2 |
| FGFR4 | Fibroblast growth factor receptor 4 |
| GAIS | Gastric-type adenocarcinoma in situ |
| GCA | Gastric-type adenocarcinoma |
| GNAS | Guanine nucleotide binding protein |
| H&E | hematoxylin eosin |
| HER2 | Human epidermal growth factor receptor 2 |
| HLA-B | Human leukocyte antigen-B |
| HPV | Human papillomavirus |
| IECC | International endocervical criteria and classification |
| IHC | immunohistochemistry |
| ISGyP | International Society of Gynecological Pathologists |
| KMT2D | Lysine methyltransferase 2D |
| KRAS | Kirsten rat sarcoma |
| LEGH | Lobular endocervical glandular hyperplasia |
| MDA | Minimal-deviation adenocarcinoma |
| MDM2 | Mouse double minute 2 |
| MECOM | MDS1 and EVI1 complex locus |
| MMA | DNA mismatch repair |
| MRI | Magnetic resonance imaging |
| MSH2 | MutS homolog 2 |
| MSH6 | MutS homolog 6 |
| MSI-H | microsatellite instability-high |
| NGS | Next generation sequencing |
| NHPVA | non-HPV adenocarcinoma |
| NTRK3 | Neurotrophic receptor tyrosine kinase 3 |
| p-mTOR | Phosphorylated mammalian target of rapamycin |
| PCR | Polymerase chain reaction |
| PD-L1 | programmed cell death ligand 1 |
| PI3K-AKT | Phosphatidylinositol-3-kinase |
| PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| POLE | polymerase epsilon |
| PTEN | Phosphatase and tensin homolog |
| PTPRS | Protein tyrosine phosphatase receptor type S |
| RISH | RNA in-situ hybridization |
| RNA | Ribonucleic acid |
| SCC | Squamous cell carcinoma |
| SLX4 | Structure-specific endonuclease subunit |
| SMAD4 | Mothers against decapentaplegic homolog 4 |
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4 |
| STK11 | Serine/threonine kinase 11 |
| TP53 | Tumor protein p53 |
| WHO | World Health Organization |